Mitochondrial dysfunction in mouse models of Parkinson’s disease revealed by transcriptomics and proteomics
Open Access
- 5 December 2009
- journal article
- review article
- Published by Springer Nature in Journal of Bioenergetics and Biomembranes
- Vol. 41 (6) , 487-491
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damageProceedings of the National Academy of Sciences, 2005
- α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cellsJournal of Cell Science, 2005
- Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag ApproachMolecular & Cellular Proteomics, 2005
- Nitric oxide, oxidants, and protein tyrosine nitrationProceedings of the National Academy of Sciences, 2004
- Biological selectivity and functional aspects of protein tyrosine nitrationBiochemical and Biophysical Research Communications, 2003
- Oxidative post‐translational modifications of α‐synuclein in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model of Parkinson's diseaseJournal of Neurochemistry, 2001
- The Protein Data BankNucleic Acids Research, 2000
- Biological Tyrosine Nitration: A Pathophysiological Function of Nitric Oxide and Reactive Oxygen SpeciesArchives of Biochemistry and Biophysics, 1998
- Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkeyBrain Research, 1997